@article{arrieta:hal-03512180,
TITLE = {ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma},
AUTHOR = {Arrieta, Victor A. and Chen, Andrew X. and Kane, J. Robert and Kang, Seong Jae and Kassab, Cynthia and Dmello, Crismita and Zhao, Junfei and Burdett, Kirsten B. and Upadhyayula, Pavan S. and Lee-Chang, Catalina and Shilati, Joseph and Jaishankar, Dinesh and Chen, Li and Gould, Andrew and Zhang, Daniel and Yuan, Jinzhou and Zhao, Wenting and Ling, Xiaoyang and Burks, Jared K. and Laffleur, Brice and Amidei, Christina and Bruce, Jeffrey N. and Lukas, Rimas and Yamaguchi, Jonathan T. and Cieremans, David and Rothschild, Gerson and Basu, Uttiya and Mccord, Matthew and Brat, Daniel J. and Zhang, Hui and Cooper, Lee A. D. and Zhang, Bin and Sims, Peter and Cloughesy, Tim F. and Prins, Robert and Canoll, Peter and Stupp, Roger and Heimberger, Amy B. and Horbinski, Craig and Iwamoto, Fabio M. and Rabadan, Raul and Sonabend, Adam M.},
URL = {https://hal.science/hal-03512180},
JOURNAL = {Nature Cancer},
PUBLISHER = {Nature Research },
VOLUME = {2},
NUMBER = {12},
PAGES = {1372-+},
YEAR = {2021},
MONTH = Dec, DOI = {10.1038/s43018-021-00260-2},
HAL_ID = {hal-03512180},
HAL_VERSION = {v1},
}